Stave Therapeutics is an early stage immuno-oncology company developing a first-in-class small molecule immunotherapy designed to overcome resistance to cancer treatment.

The company was established through a partnership between its scientific founders and Unruly Partners, a venture builder that acts as a true co-founder: bringing capital, global networks, market knowledge, and hands-on business building experience to the companies it backs. Together, the founding group brings world-class cancer science, translational drug development experience, and commercial expertise under one roof.

Stave Therapeutics

Org chart

Teams

Offices

Stave Therapeutics

Org chart

Teams

Offices

Related companies